首页> 外文期刊>Diabetes >Next Generation Sequencing Reveals the Association of DRB3~*02:02 With Type 1 Diabetes
【24h】

Next Generation Sequencing Reveals the Association of DRB3~*02:02 With Type 1 Diabetes

机译:下一代测序揭示了DRB3〜* 02:02与1型糖尿病的关联

获取原文
获取原文并翻译 | 示例
       

摘要

The primary associations of the HLA class Ⅱ genes, HLA-DRB1 and HLA-DQB1, and the class I genes, HLA-A and HLA-B, with type 1 diabetes (T1D) are well established. However, the role of polymorphism at the HLA-DRB3, HLA-DRB4, and HLA-DRB5 loci remains unclear. In two separate studies, one of 500 subjects and 500 control subjects and one of 366 DRBl~*03:01-positive samples from selected multiplex T1D families, we used Roche 454 sequencing with Conexio Genomics ASSIGN ATF 454 HLA genotyping software analysis to analyze sequence variation at these three HLA-DRB loci. Association analyses were performed on the two HLA-DRB loci haplotypes (DRB1-DRB3, -DRB4, or -DRB5). Three common HLA-DRB3 alleles (~*01:01, ~*02:02, ~*03:01) were observed. DRBl~*03:01 haplotypes carrying DRB3~*02:02 conferred a higher T1D risk than did DRBl~*03:01 haplotypes carrying DRB3~*01:01 in DRBl~*03:01y~*03:01 homozygotes with two DRB3~*01:01 alleles (odds ratio [OR] 3.4 [95% CI 1.46-8.09]), compared with those carrying one or two DRB3~*02:02 alleles (OR 25.5 [3.43-189.2]) (P = 0.033). For DRBl~*03:01/~*04:01 heterozygotes, however, the HLA-DRB3 allele did not significantly modify the T1D risk of the DRBl~*03:01 haplotype (OR 7.7 for ~*02:02; 6.8 for ~*01:01). These observations were confirmed by sequence analysis of HLA-DRB3 exon 2 in a targeted replication study of 281 informative T1D family members and 86 affected family-based association control (AFBAC) haplotypes. The frequency of DRB3~*02:02 was 42.9% in the DRBl~*03:01/~*03:01 patients and 27.6% in the DRBl~*03:01/~*04 (P = 0.005) compared with 22.6% in AFBAC DRBl~*03:01 chromosomes (P = 0.001). Analysis of T1D-associated alleles at other HLA loci (HLA-A, HLA-B, and HLA-DPB1) on DRBl~*03:01 haplotypes suggests that DRB3~*02:02 on the DRBl~*03:01 haplotype can contribute to T1D risk.
机译:众所周知,HLAⅡ类基因HLA-DRB1和HLA-DQB1与I类基因HLA-A和HLA-B与1型糖尿病(T1D)具有重要的关联。但是,在HLA-DRB3,HLA-DRB4和HLA-DRB5位点的多态性作用仍不清楚。在两项独立的研究中,来自选定的多个T1D家族的500名受试者和500名对照受试者之一,以及366个DRB1〜* 03:01阳性样品之一,我们使用了Roche 454测序和Conexio Genomics ASSIGN ATF 454 HLA基因分型软件来分析序列这三个HLA-DRB位点的变异。对两种HLA-DRB基因座单倍型(DRB1-DRB3,-DRB4或-DRB5)进行了关联分析。观察到三个常见的HLA-DRB3等位基因(〜* 01:01,〜* 02:02,〜* 03:01)。具有DRB1〜* 03:01y〜* 03:01的纯合子中携带DRB3〜* 02:02的DRB1〜* 03:01单倍型比携带DRB3〜* 01:01的DRB1〜* 03:01单倍型具有更高的T1D风险DRB3〜* 01:01等位基因(比值比[OR] 3.4 [95%CI 1.46-8.09]),而携带一或两个DRB3〜* 02:02等位基因(OR 25.5 [3.43-189.2])(P = 0.033)。然而,对于DRB1〜* 03:01 /〜* 04:01杂合子,HLA-DRB3等位基因并未显着改变DRB1〜* 03:01单倍型的T1D风险(对于** 02:02,OR 7.7;对于** 02:02,OR6.8 〜* 01:01)。这些观察结果通过针对281个信息丰富的T1D家族成员和86个受影响的基于家庭的协会控制(AFBAC)单倍型的靶向复制研究中的HLA-DRB3外显子2的序列分析得到证实。在DRB1〜* 03:01 /〜* 03:01患者中,DRB3〜* 02:02的频率为42.9%,在DRB1〜* 03:01 /〜* 04中为27.6%(P = 0.005),而22.6在AFBAC DRB1〜* 03:01染色体中的%(P = 0.001)。对DRB1〜* 03:01单倍型上其他HLA基因位点(HLA-A,HLA-B和HLA-DPB1)的T1D相关等位基因的分析表明,DRB1〜* 03:01单倍型上的DRB3〜* 02:02造成T1D风险。

著录项

  • 来源
    《Diabetes》 |2013年第7期|2618-2622|共5页
  • 作者单位

    Roche Molecular Systems, Pleasanton, California;

    King's College London, London, U.K.;

    Children's Hospital Oakland Research Institute, Oakland, California;

    454 Life Sciences-a Roche Company, Branford, Connecticut;

    454 Life Sciences-a Roche Company, Branford, Connecticut;

    454 Life Sciences-a Roche Company, Branford, Connecticut;

    Department of Medical Genetics, Cambridge Institute of Medical Research, JDRF/Wellcome Trust Diabetes and Inflammation Laboratory, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge, U.K.;

    Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia;

    Children's Hospital Oakland Research Institute, Oakland, California;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:26

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号